autologous bone marrow mononuclear cell transfusion

BIOLOGICAL2 trials

Sponsors

University of California, Irvine, Vinmec Research Institute of Stem Cell and Gene Technology

Conditions

Autism Spectrum DisorderStroke

Phase 1

Autologous Cell Therapy After Stroke

WithdrawnNCT00908856

University of California, IrvineStroke

Start: 2016-01-31End: 2017-12-31Updated: 2016-02-04

Phase 2

Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy From Brain Hypoxia

RecruitingNCT06629324

Vinmec Research Institute of Stem Cell and Gene TechnologyAutism Spectrum Disorder

Start: 2024-10-15End: 2027-01-31Target: 58Updated: 2026-01-22